Literature DB >> 3497195

High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4.

J Ohara, J E Coligan, K Zoon, W L Maloy, W E Paul.   

Abstract

B cell stimulatory factor-1/interleukin 4, a lymphokine produced by phorbol ester activated-EL-4 thymoma cells, was purified to homogeneity in good yield by a two-step purification procedure, using affinity chromatography and a single subsequent round of reverse-phase high-performance liquid chromatography. The N-terminal sequence of the first 24 amino acids was consistent with that inferred from the nucleotide sequence of BSF-1 cDNA clones. Amino acid composition analysis also agreed well with that predicted from the nucleotide sequence. A rabbit antibody to a peptide corresponding to positions 100 to 113 inferred from the nucleotide sequence of the cDNA clones bound to BSF-1 purified from EL-4 cells. Purified BSF-1 possesses complex N-linked glycosidic side chains as shown by reduction in Mr from 20,000 to approximately 15,000 by endoglycosidase F but not by endoglycosidase H treatment. Removal of these N-linked sugars does not diminish the activity of BSF-1 as a costimulant in the response of B cells to anti-IgM. By contrast, the reduction of disulfide bonds completely destroyed biologic activity. A monoclonal antibody to BSF-1 blocks its binding to cellular receptors and inhibits biological activities, whereas antibody to the BSF-1 peptide (100-113) has neither effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

Review 2.  History of interleukin-4.

Authors:  William E Paul
Journal:  Cytokine       Date:  2015-03-23       Impact factor: 3.861

3.  Cross-linking of interleukin 4 to surface molecules on murine T and B lymphocytes.

Authors:  R Fernandez-Botran; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Interleukin 4 enhances osteoblast macrophage colony-stimulating factor, but not interleukin 6, production.

Authors:  D L Lacey; J M Erdmann; M Shima; S Kling; A Matayoshi; J Ohara; S L Perkins
Journal:  Calcif Tissue Int       Date:  1994-07       Impact factor: 4.333

Review 5.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

6.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression.

Authors:  J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation.

Authors:  A D Keegan; J A Johnston; P J Tortolani; L J McReynolds; C Kinzer; J J O'Shea; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?

Authors:  F Kierszenbaum; H Mejia Lopez; M B Sztein
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

9.  Tuberculosis-induced variant IL-4 mRNA encodes a cytokine functioning as growth factor for (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-specific Vgamma2Vdelta2 T cells.

Authors:  ZhuQing Yuan; Richard Wang; Yuyang Lee; Crystal Y Chen; XingBing Yu; ZhongDao Wu; Dan Huang; Ling Shen; Zheng W Chen
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor.

Authors:  M Larche; J R Lamb; R E O'Hehir; N Imami-Shita; E D Zanders; D E Quint; R Moqbel; M A Ritter
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.